Literature DB >> 1447664

Obstructive, mixed, and central apnea in the neonate: physiologic correlates.

N N Finer1, K J Barrington, B J Hayes, A Hugh.   

Abstract

In an attempt to determine physiologic responses to neonatal apnea, we evaluated changes in heart rate and oxygen saturation as measured by pulse oximetry during 2082 episodes of apnea lasting 15 seconds or more in 47 infants less than 34 weeks of gestational age with idiopathic apnea of prematurity. Of these episodes, 832 (39.9%) were central, 1032 (49.6%) were mixed, and 218 (10.5%) were obstructive. Oxygen saturation decreased with increasing duration of apnea regardless of type or treatment, and the decrease in saturation was correlated with preapnea saturation. The baseline heart rate was similar for all apnea types. Infants receiving doxapram had a lower baseline heart rate (137.8 +/- 10.5 beats/min) than did infants receiving no therapy (142.8 +/- 16.6 beats/min) and infants receiving theophylline (149.7 +/- 15.0 beats/min) (p = < 0.001). A heart rate fall to less than 100 beats/min was seen more frequently with central apnea than with mixed or obstructive events, and in infants who were not receiving therapy. Falls in heart rate were significantly less in infants receiving doxapram (27.8% +/- 18.0%) than in infants receiving theophylline (44.5% +/- 19.0%) or no therapy (48.4% +/- 18.3%) (p = < 0.001). The most common heart rate pattern overall was a gradual decrease interrupted by accelerations, whereas an initial heart rate acceleration was the most common pattern in obstructive apnea. We conclude that heart rate response to neonatal apnea is a complex and is dependent on therapy and on type and duration of apnea.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447664     DOI: 10.1016/s0022-3476(05)80349-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Apnea in infants.

Authors:  Adrian Poblano; Aida Marquez; Guadalupe Hernandez
Journal:  Indian J Pediatr       Date:  2006-12       Impact factor: 1.967

Review 2.  Doxapram Treatment for Apnea of Prematurity: A Systematic Review.

Authors:  Roseanne J S Vliegenthart; Christine H Ten Hove; Wes Onland; Anton H L C van Kaam
Journal:  Neonatology       Date:  2016-10-20       Impact factor: 4.035

Review 3.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  Is Early Preventive Caffeine Safe and Effective in Premature Neonates? A Clinical Trial.

Authors:  Negar Sajjadian; Peymaneh Alizadeh Taheri; Mahboobeh Jabbari
Journal:  Int J Pediatr       Date:  2022-06-02

5.  Sleep and breathing in premature infants at 6 months post-natal age.

Authors:  Yu-Shu Huang; Teresa Paiva; Jen-Fu Hsu; Ming-Chun Kuo; Christian Guilleminault
Journal:  BMC Pediatr       Date:  2014-12-16       Impact factor: 2.125

6.  Perinatal Hypoxemia and Oxygen Sensing.

Authors:  Gary C Mouradian; Satyan Lakshminrusimha; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

7.  Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses.

Authors:  Eilan Alhersh; Dina Abushanab; Samaher Al-Shaibi; Daoud Al-Badriyeh
Journal:  Paediatr Drugs       Date:  2020-08       Impact factor: 3.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.